Status:
COMPLETED
Study of the Influence of Blue Light Emitted by Computer / Television Screens on Melasma MELABLUE Study
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Melasma
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Melasma is a fairly common condition resulting in hyperpigmented macules on the face. Melasma is difficult to treat and has a significant negative impact on the patient's quality of life. Melasma is ...
Eligibility Criteria
Inclusion
- Female patient, 18 years of age and older, phototype II to V on the Fitzpatrick scale
- Patient with a clinically diagnosed diagnosis of melasma.
- Patient without a serious medical history and declared fit to participate in the medical visit.
- Patient who has signed a written informed consent form before any action related to the study is initiated.
- If the patient is able to procreate, she should use reliable contraception (contraceptive pill, contraceptive implant, intrauterine contraceptive device, bilateral tubal ligation / section, condoms), and agree not to change contraceptive status for at least one month before the start of the study and throughout the duration of the study.
Exclusion
- Women who are pregnant or breastfeeding or who have planned a pregnancy during the course of the study.
- Patient with another pigment condition on the face.
- Patient who used depigmenting cosmetic on the face in the two weeks prior to inclusion.
- Patient who used a local corticosteroid on the face or systemic steroids during the month prior to inclusion.
- Patient who used local tretinoin or local hydroquinone during the month prior to inclusion.
- Patient who took systemic or topical photosensitizing treatments during the month preceding the first day of the study (1 month or 5 half-lives, the longest possible duration),
- Patient with a history of photodermatoses.
- Patient spending more than 3 hours a day in front of a screen (computer, LED TV, tablet, phone etc ...) for professional or private reasons.
Key Trial Info
Start Date :
April 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 22 2019
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03877445
Start Date
April 11 2019
End Date
July 22 2019
Last Update
December 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Pharmacologie Clinique Appliquée à la Dermatologie
Nice, France